Results 151 to 160 of about 45,716 (246)

Key Drivers of Soil CO2, CH4, and N2O Fluxes in Conifer and Broadleaf Afforestation Systems in the Southeastern U.S.: A Machine Learning Analysis

open access: yesGlobal Change Biology Communications, Volume 1, Issue 3, September 2026.
Soil CO2 and CH4 emissions were higher in broadleaf than conifer afforestation systems in the southeastern U.S., particularly during the growing season. Machine learning analyses identified soil temperature, moisture, and atmospheric conditions as key drivers, emphasizing that soil greenhouse gas responses critically influence the climate mitigation ...
Jianing Liang   +24 more
wiley   +1 more source

Cardiovascular Diseases: Exploring Epidemiology, Pathophysiology, Risk Factors, and Medicinal Plant‐Based Therapies: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, encompassing coronary artery disease, hypertension, heart failure, and cerebrovascular disorders. The global burden of CVD continues to rise, driven by complex interactions among endothelial dysfunction, oxidative stress, inflammation,
Nawfal Hasan Siam   +8 more
wiley   +1 more source

hs-CRP as a Marker of Systemic Low-Grade Inflammation Is Not Associated with Steatotic Liver Disease in Adolescents: Insights from the EVA4YOU Study. [PDF]

open access: yesMetabolites
Nairz J   +5 more
europepmc   +1 more source

Rational Monitoring of Patients With Inflammatory Bowel Disease in Remission: Results From the Danish DK‐MONITOR Delphi Consensus Study

open access: yesJCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background Monitoring strategies for patients with inflammatory bowel disease (IBD) in remission vary widely in clinical practice, reflecting limited evidence and a lack of consensus. With increasing numbers of patients living long term with IBD, there is a need for rational, clinically meaningful approaches to remission‐phase monitoring ...
Johan Burisch   +42 more
wiley   +1 more source

Resveratrol: Advance on the Most Recent Research From 2021 to 2025

open access: yesPhytochemicals in Food and Medicine, Volume 1, Issue 3, September 2026.
This review summarizes recent progress in resveratrol research (2021–2025), highlighting its natural sources, bioactivities, clinical evidence, and safety profiles. Resveratrol exerts multi‐target effects through the regulation of oxidative stress, inflammation, mitochondrial function, and gut microbiota.
Quanyong Wu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy